Irish exports surge in September driven by Pharma strength - CSO

Ireland recorded a sharp rise in exports in September, with new CSO figures highlighting a strong month-on-month and year-on-year performance. Exports increased by almost 60% (57.1%) to €27.4 billion, adding €10 billion to August’s tally of just under €17.5 billion.

The CSO’s Q3 2025 release also shows that exports are up €6.2 billion to €28.5 billion (+27.8%) compared with September 2024. The main driver of this surge is the pharmaceutical sector, reflecting the continued strength of Ireland’s export economy in this area.

Carol Lynch, Partner & Head of Customs and International Trade Services, examines the latest CSO figures. 

 

The US continues to be our top exporting partner in September, with 57.1% of our overall exports going to the US. Also positive is that exports to GB increased by 22.4% in September 2025 versus September 2024. While US trade policy will continue to have a significant impact on many Irish exporters, the worst predictions in relation to Pharma exports have not materialised as these companies announce investments in the US and introduce reductions in drug prices. We also saw the introduction of some reductions in tariffs in the food and agri area this month, to balance inflation on food products in the US. Irish food and agri exporters should check to see if their products are on this list, which includes, for example, many beef products.

Carol LynchPartner and Head of Customs & International Trade Services, BDO Ireland

In addition, exports to the US grew by 126% (€9.1 billion) to €16.3 billion in September 2025 versus September 2024. Year-to-date exports to the US now exceed €100 billion, compared with €52 billion last year, representing a doubling of export value. This increase is reflected largely in chemicals and related products.

Medical and pharmaceutical exports rose by 73.6% (€7.9 billion) to €18.7 billion in September 2025 versus September 2024.


Find out how BDO experts can help your business

Learn more